We fight for human health.

CureVac is the first company to successfully harness messenger RNA (mRNA) for medical purposes. The principle is promising; use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases.

  • Study with CureVac’s RNAdjuvant® Technology Published

    Press Release of December 05, 2016

    Read more
  • CureVac Secures an Additional $29.5 Million From Two New Investors

    Press Notice of November 08, 2016

    Read more
  • CureVac Receives Broad Patent for RNAntibody® Technology

    Press Release of November 08, 2016

    Read more
  • "Enabling the Body to Manufacture Its Own Medicine"

    Media Report, GEN (Genetic Engineering & Biotechnology News), November 1, 2016

    Read more
  • Study in Peer-Reviewed Journal Vaccine Demonstrates Decoding Mode of Action of mRNA Vaccines

    Press Release of July 14, 2016

    Read more
  • Work@CureVac

    Do you want to fight together with us for human health? You will find current vacancies on our CareerPortal.

    Read more